Total : 3 View more »
VAUGHAN, ON, Nov. 9, 2009 (Canada NewsWire via COMTEX) --
PRISM MEDICAL LTD. (TSX-V:PM) ("Prism") today announced that it has completed the acquisition of a UK supplier of moving and handling services for the mobility impaired effective November 6, 2009. The acquisition cost was $0.8m which was satisfied by a cash payment of $0.4m and deferred payments in the amount $0.4m. The deferred payments are repayable over 3 years together with interest at 7% over a term of 3 years.
The company services and maintains a wide variety of equipment including ceiling lifts, baths and beds into both long term care and acute care facilities throughout England and Wales.
Andrew A. McIntyre, Chairman and CEO of Prism stated, "The acquisition continues our expansion into the provision of services for our customers. The acquisition is expected to be accretive to earnings in the current fiscal year and will strengthen Prism's ability to execute its strategic plans."
About Prism
Prism Medical Ltd. is a provider of durable medical equipment and related services to the mobility disadvantaged in Canada, the U.S.A. and the United Kingdom. While Prism's history dates back to 1996, Prism's subsidiaries and divisions have been servicing the mobility disadvantaged since the mid 1980s in their homes, long-term care facilities and acute care facilities. Prism includes Waverley Glen and ErgoSafe Products, North America's premier lifting & handling equipment and repositioning aid manufacturer with distribution across Canada and the U.S., Westholme and Care Free Lifting & Handling, leading distributors of moving and handling products in the UK, and Freeway Health Care, a UK-based manufacturer of ceiling hoists and shower chairs.
Forward-looking Information
Certain statements in this release may constitute forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors, which may cause actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements.
%SEDAR: 00009348E
SOURCE: Prism Medical Ltd.
William G. Edwards, Chief Financial Officer, Prism Medical Ltd., Tel: (416) 260-2145 (Ext. 230), wgedwards@prismmedicalltd.com
Tags: acquisition canada ceo earnings england expansion health manufacturer medical north america products
Companies: Prism Medical Ltd (PM), Prism Medical Ltd (PSDLF)
VAUGHAN, ON, Oct. 16, 2009 (Canada NewsWire via COMTEX) --
Prism Medical Ltd. ("Prism" or "the Company") (PM:TSX-VEN) today announced its results for the third quarter ended August 31, 2009.
Net income for the third quarter of 2009 decreased to $820 thousand ($0.13 per share on a diluted basis) versus $1.065 million ($0.16 per share on a diluted basis) for the same period in 2008.
During the third quarter of 2009, revenues were $15.1 million compared to $12.4 million in 2008, an increase of 22%, driven by an increase in sales within the United States and the UK. The Company continues to focus its efforts on the US marketplace through enhanced sales initiatives and geographical coverage. In the UK, sales increased 25% after incorporating the impact of a decline in the British Pound Sterling (GBP) relative to the Canadian dollar.
In the third quarter of 2009, gross profit increased $927 (16%) over the same period in 2008 driven by the sales increase and higher percentage of sales made by the Company owned network of dealers and direct sales staff. Selling, general and administration expenses increased $1,180 (34%) over the same period last year primarily as a result of incorporating the operating costs of new acquisitions and infrastructure costs incurred within the US.
Earnings per share on a diluted basis for the three months ended August 31, 2009 of $0.13 per share represents a decrease of 18% over the same period last year.
In the third quarter of 2009, EBITDA was $2,098 vs. $2,434 over the same period in 2008. The weakening of the British pound sterling on a year over year basis reduced EBITDA in the third quarter of 2009 by $220 CDN.
Andrew McIntyre, Chairman and CEO of Prism stated "the third quarter of 2009 was positive for the Company as we saw continued institutional demand for our products, improved manufacturing efficiencies and greater geographic coverage in the current economic climate. Further improvements in US sales representation and dealer market share should result in future profitable growth."
Prism Medical Ltd. is a provider of durable medical equipment and related services to the mobility disadvantaged in Canada, the USA and the United Kingdom. While Prism's history dates back to 1996, Prism's subsidiaries and divisions have been servicing the mobility disadvantaged since the mid 1980s in their homes, long-term care facilities and acute care facilities. Prism includes Waverley Glen Systems, North America's premier lifting, handling and repositioning aid manufacturer with distribution across Canada and the US; Patient Lifts of New England with distribution across the northeastern USA; Westholme and Care Free Lifting & Handling, leading distributors of moving and handling products in the UK; and Freeway Health Care, a UK-based manufacturer of ceiling hoists and shower chairs.
Forward-looking Information
Certain statements in this release may constitute forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors, which may cause actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements.
%SEDAR: 00009348E
SOURCE: Prism Medical Ltd.
William G. Edwards, Chief Financial Officer, Prism Medical Ltd., Tel: (905) 850-0093 ext. 242, Fax: (905) 850-0061, wgedwards@prismmedicalltd.com, www.prismmedicalltd.com
Tags: canada ceo dealer dollar earnings ebitda financial results health manufacturer manufacturing market share medical north america pound products sales sterling
Companies: Prism Medical Ltd (PM), Prism Medical Ltd (PSDLF)
VAUGHAN, ON, Oct. 19, 2009 (Canada NewsWire via COMTEX) --
Prism Medical Ltd. ("Prism") (PM:TSX-VEN) announced today that the directors have approved payment of a dividend of $0.075 per common share on November 5, 2009 to the shareholders of record on October 28, 2009.
Prism also announced today that the board of directors approved the appointment of Raymond James & Associates, Inc. to act as a financial advisor to the company. In such capacity, Raymond James & Associates, Inc. will independently assess the value of the company and review strategic alternatives with a view to increasing shareholder liquidity and maximizing shareholder value.
<<
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this press release.
>>
%SEDAR: 00009348E
SOURCE: Prism Medical Ltd.
Andrew McIntyre, President, Chief Executive Officer and Chairman, Prism Medical Ltd., Tel: (416) 260-2145 ext. 235, Fax: (416) 260-9195, prism@prismmedicalltd.com, www.prismmedicalltd.com
Companies: Prism Medical Ltd (PM), Prism Medical Ltd (PSDLF)
Total : 2 View more »
The Prism medical coating systems feature USI's patented nozzle-free ultrasonic technology, which is industry proven and delivers a more precise coating application than conventional spray nozzles.
© 2009 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.
http://stlouis.bizjournals.com/stlouis/related_content.html?topic=Prism%20Medical%20Services%20USA
Total : 25 View more »
Our parent company, Prism Medical Limited, is a global company dedicated to the provision of medical equipment of the highest quality. Call us - we will de delighted to help
Discounted Rates for Same Day STD Testing w/ Rapid Resulting Press Release ... Prism Medical Limited (2) Progenics Pharmaceuticals Incorporated (3) Quantum Group Incorporated (1)
http://www.zibb.com/healthcare/interstitial/news/Healthcare_Care
Bill Peckham blogs about Sen. Daschle and what his appointment as HHS secretary ... Prism Medical Limited (2) Progenics Pharmaceuticals Incorporated (3) PSS World Medical Incorporated (1)
http://www.zibb.com/healthcare/interstitial/all/Healthcare_Care
Prism Medical Limited Oct p. 14 Prism Venture Partners Mar p. 7, Mar p. 8, Apr p. 8, May p. 8, Oct p. 7 Private Equity Direct Finance Sep p. 8 Privateq Advisors Jun p. 15
http://www.levinassociates.com/publications/jenks/jenks%20index/04jenksindex.htm